| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Achieve Life Sciences (NASDAQ:ACHV) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Achieve Life Sciences will report an earnings per share (EPS) of $-0.36.
The market awaits Achieve Life Sciences's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Last quarter the company missed EPS by $0.00, which was followed by a 9.25% drop in the share price the next day.
Here's a look at Achieve Life Sciences's past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.36 | -0.26 | -0.23 | -0.23 |
| EPS Actual | -0.36 | -0.36 | -0.25 | -0.26 |
| Price Change % | -9.0% | -7.000000000000001% | 1.0% | 2.0% |
Shares of Achieve Life Sciences were trading at $2.35 as of May 09. Over the last 52-week period, shares are down 50.6%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Achieve Life Sciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ACHV
